Barely Significant
← all phrases

“highly significant”

132,143 sentences · 132,143 papers · 160,126 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013)

In the literature

highly significantp < 0.00010.0× alphaqualifiedgold
Tukey’s multiple comparison test showed highly significant differences between the control and remission groups ( p < 0.0001), the control and active phase groups ( p < 0.0001), as well as between the remission and active phase groups ( p < 0.0001).
highly significantP < 0.00010.0× alphaqualifiedgold
Other Clinical Efficacy Results The mean changes from baseline in the IKDC subjective score, which ranges from 0 (worst result) to 100 (best result), were highly significant at all time points (i.e., P < 0.0001; including Month 3) and increased in their extent through Month 24 (LS mean increase from baseline: 41.6 ± 1.9 points; 95% CI: 37.9-45.4).
highly significantp < 0.00010.0× alphaqualifiedgold
(2022) found no significant differences in input resistance and spike width between Calb2 and Chrna2 cells, whereas we found highly significant differences in these parameters ( p < 0.0001 and p = 0.01, respectively, in pairwise comparisons), and also in the initial firing frequency and adaptation ratio (Extended Data Fig. 9-1 ).
highly significantP < 0.00010.0× alphaqualifiedgold
When hair follicle harvested from lower occipital donor area of Group ’A’ and Group ’B’ patients were compared and we observed highly significant statistical difference between these two groups (df = 10, t = 18.77, P < 0.0001) [ Table 2 ] Average FTR from total scalp donor area in Group ’A’ and Group ’B’ patients was 5.10 and 3.10, respectively [ Table 4 ].
highly significantp < 0.00010.0× alphaqualifiedgold
➣ Subgrouping of vaccinated cases according to used vaccine revealed three groups: Group 1: Pts received viral vector-based vaccines with adverse events Group 2: Pts received mRNA-based vaccines with adverse events Group 3: Pts received inactivated virus vaccines with adverse events Comparing each two groups as regards adverse events done and revealed the following results Comparing group 1 to group 2 Viral vector-based vaccine group (group 1) showed highly significant increase in cases of thrombotic thrombocytopenic purpura/cerebral venous thrombosis/pulmonary embolism with p < 0.0001 In the same context, group 1 had statistically significant increase in cases of DIC ( P = 0.0316), GBS ( P = 0.0036) and ATM ( P = 0.0089).